Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Long-term outcomes following first short-term clinically important deterioration in COPD.

Naya IP, Tombs L, Muellerova H, Compton C, Jones PW.

Respir Res. 2018 Nov 20;19(1):222. doi: 10.1186/s12931-018-0928-3.

2.

Chronic airway obstruction in a population-based adult asthma cohort: Prevalence, incidence and prognostic factors.

Backman H, Jansson SA, Stridsman C, Muellerova H, Wurst K, Hedman L, Lindberg A, Rönmark E.

Respir Med. 2018 May;138:115-122. doi: 10.1016/j.rmed.2018.03.036. Epub 2018 Apr 3.

PMID:
29724382
3.

Development of a Conceptual Model of Disease Progression for Use in Economic Modeling of Chronic Obstructive Pulmonary Disease.

Tabberer M, Gonzalez-McQuire S, Muellerova H, Briggs AH, Rutten-van Mölken MPMH, Chambers M, Lomas DA.

Med Decis Making. 2017 May;37(4):440-452. doi: 10.1177/0272989X16662009. Epub 2016 Aug 2.

PMID:
27486218
4.

Lung Function Abnormalities in Smokers with Ischemic Heart Disease.

Franssen FM, Soriano JB, Roche N, Bloomfield PH, Brusselle G, Fabbri LM, García-Rio F, Kearney MT, Kwon N, Lundbäck B, Rabe KF, Raillard A, Muellerova H, Cockcroft JR.

Am J Respir Crit Care Med. 2016 Sep 1;194(5):568-76. doi: 10.1164/rccm.201512-2480OC.

PMID:
27442601
5.

Development of the Galaxy Chronic Obstructive Pulmonary Disease (COPD) Model Using Data from ECLIPSE: Internal Validation of a Linked-Equations Cohort Model.

Briggs AH, Baker T, Risebrough NA, Chambers M, Gonzalez-McQuire S, Ismaila AS, Exuzides A, Colby C, Tabberer M, Muellerova H, Locantore N, Rutten van Mölken MPMH, Lomas DA.

Med Decis Making. 2017 May;37(4):469-480. doi: 10.1177/0272989X16653118. Epub 2016 Jun 17.

PMID:
27317436
6.

Statistical Modeling of Disease Progression for Chronic Obstructive Pulmonary Disease Using Data from the ECLIPSE Study.

Exuzides A, Colby C, Briggs AH, Lomas DA, Rutten-van Mölken MPMH, Tabberer M, Chambers M, Muellerova H, Locantore N, Risebrough NA, Ismaila AS, Gonzalez-McQuire S.

Med Decis Making. 2017 May;37(4):453-468. doi: 10.1177/0272989X15610781. Epub 2015 Oct 8.

PMID:
26449490
7.

Continuing to confront COPD International Surveys: comparison of patient and physician perceptions about COPD risk and management.

Menezes AM, Landis SH, Han MK, Muellerova H, Aisanov Z, van der Molen T, Oh YM, Ichinose M, Mannino DM, Davis KJ.

Int J Chron Obstruct Pulmon Dis. 2015 Jan 20;10:159-72. doi: 10.2147/COPD.S74315. eCollection 2015.

8.

Continuing to Confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countries.

Davis KJ, Landis SH, Oh YM, Mannino DM, Han MK, van der Molen T, Aisanov Z, Menezes AM, Ichinose M, Muellerova H.

Int J Chron Obstruct Pulmon Dis. 2014 Dec 30;10:39-55. doi: 10.2147/COPD.S70162. eCollection 2015.

9.

Validating A Model To Predict Disease Progression Outcomes In Patients With COPD.

Risebrough NA, Briggs A, Baker TM, Exuzides A, Colby C, Rutten van-Molken M, Gonzalez McQuire S, Lomas D, Muellerova H, Tal-Singer R, Ismaila A.

Value Health. 2014 Nov;17(7):A560-1. doi: 10.1016/j.jval.2014.08.1852. Epub 2014 Oct 26. No abstract available.

10.

Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.

Wurst KE, Shukla A, Muellerova H, Davis KJ.

COPD. 2014 Sep;11(5):521-30. doi: 10.3109/15412555.2014.922064. Epub 2014 Jun 19.

PMID:
24945236
11.

Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012-2013.

Landis SH, Muellerova H, Mannino DM, Menezes AM, Han MK, van der Molen T, Ichinose M, Aisanov Z, Oh YM, Davis KJ.

Int J Chron Obstruct Pulmon Dis. 2014 Jun 6;9:597-611. doi: 10.2147/COPD.S61854. eCollection 2014.

12.

GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.

Han MK, Muellerova H, Curran-Everett D, Dransfield MT, Washko GR, Regan EA, Bowler RP, Beaty TH, Hokanson JE, Lynch DA, Jones PW, Anzueto A, Martinez FJ, Crapo JD, Silverman EK, Make BJ.

Lancet Respir Med. 2013 Mar;1(1):43-50. doi: 10.1016/S2213-2600(12)70044-9. Epub 2012 Sep 3.

13.

Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale.

Al-shair K, Muellerova H, Yorke J, Rennard SI, Wouters EF, Hanania NA, Sharafkhaneh A, Vestbo J; ECLIPSE investigators.

Health Qual Life Outcomes. 2012 Aug 23;10:100. doi: 10.1186/1477-7525-10-100.

14.

Up-to-date on mortality in COPD - report from the OLIN COPD study.

Lindberg A, Larsson LG, Muellerova H, Rönmark E, Lundbäck B.

BMC Pulm Med. 2012 Jan 9;12:1. doi: 10.1186/1471-2466-12-1.

15.

A 20-year follow-up of a population study-based COPD cohort-report from the obstructive lung disease in Northern Sweden studies.

Lundbäck B, Eriksson B, Lindberg A, Ekerljung L, Muellerova H, Larsson LG, Rönmark E.

COPD. 2009 Aug;6(4):263-71.

PMID:
19811385
16.

Geographic differences in clinical characteristics and management of COPD: the EPOCA study.

Miravitlles M, Murio C, Tirado-Conde G, Levy G, Muellerova H, Soriano JB, Ramirez-Venegas A, Ko FW, Canelos-Estrella B, Giugno E, Bergna M, Chérrez I, Anzueto A.

Int J Chron Obstruct Pulmon Dis. 2008;3(4):803-14.

17.

COPD prevalence in a random population survey: a matter of definition.

Shirtcliffe P, Weatherall M, Marsh S, Travers J, Hansell A, McNaughton A, Aldington S, Muellerova H, Beasley R.

Eur Respir J. 2007 Aug;30(2):232-9.

18.

Patterns of comorbidities in newly diagnosed COPD and asthma in primary care.

Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL.

Chest. 2005 Oct;128(4):2099-107.

PMID:
16236861

Supplemental Content

Loading ...
Support Center